August 20, 2026/
Dr. Vinay Rao VP – R&D & Head – Center of Excellence The pharmaceutical industry is increasingly challenged by drug molecules with poor aqueous solubility. A large proportion of modern active pharmaceutical ingredients (APIs) fall into BCS Class II and IV categories, where dissolution and bioavailability become critical barriers to successful...
